María José Gallardo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
María José Gallardo has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Mario Suwalsky
Faculty of Chemical Sciences, University of Concepcion, Concepcion, Chile
10 shared publications Kazimierz Strzalka
Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland; Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
6 shared publicationsMalgorzata Jemiola-Rzeminska
Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland; Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland
6 shared publicationsFernando Villena
Faculty of Biological Sciences, University of Concepción, Concepción, Chile
5 shared publications- Pablo Zambrano
Technical University of Munich
4 shared publications - Marcela Manrique-Moreno
Chemistry Institute, Faculty of Exact and Natural Sciences, University of Antioquia-UdeA, A.A 1226, Medellin 050010, Colombia
3 shared publications
Latest Publications
- Open Access
Effect of COVID-19 Infection on the Immune Response to the SARS-CoV-2 Vaccine in Rheumatoid Patients
Rheumatic diseases affect the musculoskeletal system and may also compromise internal organs. The immunosuppressive treatments commonly used in these conditions can weaken the immune system, raising concerns about the efficacy of immunizations, particularly against SARS-CoV-2. This observational and analytical study evaluated the humoral immune response in patients with rheumatic diseases who were vaccinated with a fourth dose of the SARS-CoV-2 vaccine in comparison with a control group and the effect prior COVID-19 infection. The results showed that individuals with a history of COVID-19 infection developed significantly higher levels of neutralizing antibody titers, indicating a stronger immune response. Moreover, the response on the Wuhan strain elicited a more robust humoral response than the Omicron strain in both immunocompromised patients and healthy controls. These findings highlight the impact of previous viral exposure on the effectiveness of immunization in rheumatology patients.
Open AccessEffect of COVID-19 Infection on the Immune Response to the SARS-CoV-2 Vaccine in Rheumatoid Patients
Rheumatic diseases affect the musculoskeletal system and may also compromise internal organs. The immunosuppressive treatments commonly used in these conditions can weaken the immune system, raising concerns about the efficacy of immunizations, particularly against SARS-CoV-2. This observational and analytical study evaluated the humoral immune response in patients with rheumatic diseases who were vaccinated with a fourth dose of the SARS-CoV-2 vaccine in comparison with a control group and the effect prior COVID-19 infection. The results showed that individuals with a history of COVID-19 infection developed significantly higher levels of neutralizing antibody titers, indicating a stronger immune response. Moreover, the response on the Wuhan strain elicited a more robust humoral response than the Omicron strain in both immunocompromised patients and healthy controls. These findings highlight the impact of previous viral exposure on the effectiveness of immunization in rheumatology patients.
- Open Access
- 26 July 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1427501
4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients
Objective: to evaluate the immune response to the SARS-CoV-2 vaccines in adults with immune-mediated rheumatic diseases (IMRDs) in comparison to healthy individuals, observed 1-20 weeks following the fourth vaccine dose. Additionally, to evaluate the impact of immunosuppressive therapies, vaccination schedules, the time interval between vaccination and sample collection on the vaccine’s immune response.Methods: We designed a longitudinal observational study conducted at the rheumatology department of Hospital de Copiapó. Neutralizing antibodies (Nabs) titers against the Wuhan and Omicron variant were analyzed between 1-20 weeks after administration of the fourth dose of the SARS-CoV-2 vaccine to 341 participants (218 IMRD patients and 123 healthy controls). 218 IMRD patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), systemic vasculitis (VS) and systemic scleroderma (SS) were analyzed.Results: Performing a comparison between the variants, Wuhan vs Omicron, we noticed that there were significant differences (p50, both for healthy controls and for patients with IMRDs. The humoral response of patients with IMRDs is significantly lower compared to healthy controls for the Omicron variant of SARS-CoV-2 (p = 0.0015). The humoral response of patients with IMRDs decreases significantly when the time interval between vaccination and sample collection is greater than 35 days. This difference was observed in the response, both for the Wuhan variant and for the Omicron variant.Conclusion: The IMRDs patients, the humoral response variation in the SARS-CoV-2 vaccine depends on doses and type of vaccine administered, the humoral response times and the treatment that these patients are receiving.
- 26 July 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1427501
Open Access4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients
Objective: to evaluate the immune response to the SARS-CoV-2 vaccines in adults with immune-mediated rheumatic diseases (IMRDs) in comparison to healthy individuals, observed 1-20 weeks following the fourth vaccine dose. Additionally, to evaluate the impact of immunosuppressive therapies, vaccination schedules, the time interval between vaccination and sample collection on the vaccine’s immune response.Methods: We designed a longitudinal observational study conducted at the rheumatology department of Hospital de Copiapó. Neutralizing antibodies (Nabs) titers against the Wuhan and Omicron variant were analyzed between 1-20 weeks after administration of the fourth dose of the SARS-CoV-2 vaccine to 341 participants (218 IMRD patients and 123 healthy controls). 218 IMRD patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), systemic vasculitis (VS) and systemic scleroderma (SS) were analyzed.Results: Performing a comparison between the variants, Wuhan vs Omicron, we noticed that there were significant differences (p50, both for healthy controls and for patients with IMRDs. The humoral response of patients with IMRDs is significantly lower compared to healthy controls for the Omicron variant of SARS-CoV-2 (p = 0.0015). The humoral response of patients with IMRDs decreases significantly when the time interval between vaccination and sample collection is greater than 35 days. This difference was observed in the response, both for the Wuhan variant and for the Omicron variant.Conclusion: The IMRDs patients, the humoral response variation in the SARS-CoV-2 vaccine depends on doses and type of vaccine administered, the humoral response times and the treatment that these patients are receiving.
- Open Access
- 18 January 2023
- Published by MDPI AG in Mathematics
- Vol. 11 (3) , 518
The Slash Half-Normal Distribution Applied to a Cure Rate Model with Application to Bone Marrow Transplantation
This paper proposes, for the first time, the use of an asymmetric positive and heavy-tailed distribution in a cure rate model context. In particular, it introduces a cure-rate survival model by assuming that the time-to-event of interest follows a slash half-normal distribution and that the number of competing causes of the event of interest follows a power series distribution, which defines six new cure rate models. Several properties of the model are derived and an alternative expression for the cumulative distribution function of the model is presented, which is very useful for the computational implementation of the model. A procedure based on the expectation–maximization algorithm is proposed for the parameter estimation. Two simulation studies are performed to assess some properties of the estimators, showing the good performance of the proposed estimators in finite samples. Finally, an application to a bone marrow transplant data set is presented.
- 18 January 2023
- Published by MDPI AG in Mathematics
- Vol. 11 (3) , 518
Open AccessThe Slash Half-Normal Distribution Applied to a Cure Rate Model with Application to Bone Marrow Transplantation
This paper proposes, for the first time, the use of an asymmetric positive and heavy-tailed distribution in a cure rate model context. In particular, it introduces a cure-rate survival model by assuming that the time-to-event of interest follows a slash half-normal distribution and that the number of competing causes of the event of interest follows a power series distribution, which defines six new cure rate models. Several properties of the model are derived and an alternative expression for the cumulative distribution function of the model is presented, which is very useful for the computational implementation of the model. A procedure based on the expectation–maximization algorithm is proposed for the parameter estimation. Two simulation studies are performed to assess some properties of the estimators, showing the good performance of the proposed estimators in finite samples. Finally, an application to a bone marrow transplant data set is presented.
- Open Access
Use of Cocktail of Bacteriophage for Salmonella Typhimurium Control in Chicken Meat
Foodborne diseases are extremely relevant and constitute an area of alert for public health authorities due to the high impact and number of people affected each year. The food industry has implemented microbiological control plans that ensure the quality and safety of its products; however, due to the high prevalence of foodborne diseases, the industry requires new microbiological control systems. One of the main causative agents of diseases transmitted by poultry meat is the bacterium Salmonella enterica. Disinfectants, antibiotics, and vaccines are used to control this pathogen. However, they have not been efficient in the total elimination of these bacteria, with numerous outbreaks caused by this bacterium observed today, in addition to the increase in antibiotic-resistant bacteria. The search for new technologies to reduce microbial contamination in the poultry industry continues to be a necessity and the use of lytic bacteriophages is one of the new solutions. In this study, 20 bacteriophages were isolated for Salmonella spp. obtained from natural environments and cocktails composed of five of them were designed, where three belonged to the Siphoviridae family and two to the Microviridae family. This cocktail was tested on chicken meat infected with Salmonella Typhimurium at 10 °C, where it was found that this cocktail was capable of decreasing 1.4 logarithmic units at 48 h compared to the control.
Open AccessUse of Cocktail of Bacteriophage for Salmonella Typhimurium Control in Chicken Meat
Foodborne diseases are extremely relevant and constitute an area of alert for public health authorities due to the high impact and number of people affected each year. The food industry has implemented microbiological control plans that ensure the quality and safety of its products; however, due to the high prevalence of foodborne diseases, the industry requires new microbiological control systems. One of the main causative agents of diseases transmitted by poultry meat is the bacterium Salmonella enterica. Disinfectants, antibiotics, and vaccines are used to control this pathogen. However, they have not been efficient in the total elimination of these bacteria, with numerous outbreaks caused by this bacterium observed today, in addition to the increase in antibiotic-resistant bacteria. The search for new technologies to reduce microbial contamination in the poultry industry continues to be a necessity and the use of lytic bacteriophages is one of the new solutions. In this study, 20 bacteriophages were isolated for Salmonella spp. obtained from natural environments and cocktails composed of five of them were designed, where three belonged to the Siphoviridae family and two to the Microviridae family. This cocktail was tested on chicken meat infected with Salmonella Typhimurium at 10 °C, where it was found that this cocktail was capable of decreasing 1.4 logarithmic units at 48 h compared to the control.
- 14 October 2021
- Published by Springer Nature in International Journal of Science and Mathematics Education
- Vol. 20 (8) , 1841-1857
Interest in Physics After Experimental Activities with a Mobile Application: Gender Differences
- 14 October 2021
- Published by Springer Nature in International Journal of Science and Mathematics Education
- Vol. 20 (8) , 1841-1857
Interest in Physics After Experimental Activities with a Mobile Application: Gender Differences
- Open Access
- 3 September 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (17) , 9563
Protective Role of a Donepezil-Huprine Hybrid against the β-Amyloid (1-42) Effect on Human Erythrocytes
Aβ(1-42) peptide is a neurotoxic agent strongly associated with the etiology of Alzheimer’s disease (AD). Current treatments are still of very low effectiveness, and deaths from AD are increasing worldwide. Huprine-derived molecules have a high affinity towards the enzyme acetylcholinesterase (AChE), act as potent Aβ(1-42) peptide aggregation inhibitors, and improve the behavior of experimental animals. AVCRI104P4 is a multitarget donepezil-huprine hybrid that improves short-term memory in a mouse model of AD and exerts protective effects in transgenic Caenorhabditis elegans that express Aβ(1-42) peptide. At present, there is no information about the effects of this compound on human erythrocytes. Thus, we considered it important to study its effects on the cell membrane and erythrocyte models, and to examine its protective effect against the toxic insult induced by Aβ(1-42) peptide in this cell and models. This research was developed using X-ray diffraction and differential scanning calorimetry (DSC) on molecular models of the human erythrocyte membrane constituted by lipid bilayers built of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE). They correspond to phospholipids representative of those present in the external and internal monolayers, respectively, of most plasma and neuronal membranes. The effect of AVCRI104P4 on human erythrocyte morphology was studied by scanning electron microscopy (SEM). The experimental results showed a protective effect of AVCRI104P4 against the toxicity induced by Aβ(1-42) peptide in human erythrocytes and molecular models.
- 3 September 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (17) , 9563
Open AccessProtective Role of a Donepezil-Huprine Hybrid against the β-Amyloid (1-42) Effect on Human Erythrocytes
Aβ(1-42) peptide is a neurotoxic agent strongly associated with the etiology of Alzheimer’s disease (AD). Current treatments are still of very low effectiveness, and deaths from AD are increasing worldwide. Huprine-derived molecules have a high affinity towards the enzyme acetylcholinesterase (AChE), act as potent Aβ(1-42) peptide aggregation inhibitors, and improve the behavior of experimental animals. AVCRI104P4 is a multitarget donepezil-huprine hybrid that improves short-term memory in a mouse model of AD and exerts protective effects in transgenic Caenorhabditis elegans that express Aβ(1-42) peptide. At present, there is no information about the effects of this compound on human erythrocytes. Thus, we considered it important to study its effects on the cell membrane and erythrocyte models, and to examine its protective effect against the toxic insult induced by Aβ(1-42) peptide in this cell and models. This research was developed using X-ray diffraction and differential scanning calorimetry (DSC) on molecular models of the human erythrocyte membrane constituted by lipid bilayers built of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE). They correspond to phospholipids representative of those present in the external and internal monolayers, respectively, of most plasma and neuronal membranes. The effect of AVCRI104P4 on human erythrocyte morphology was studied by scanning electron microscopy (SEM). The experimental results showed a protective effect of AVCRI104P4 against the toxicity induced by Aβ(1-42) peptide in human erythrocytes and molecular models.
- 1 June 2019
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1861 (6) , 1078-1085
The acetylcholinesterase (AChE) inhibitor and anti-Alzheimer drug donepezil interacts with human erythrocytes
- 1 June 2019
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1861 (6) , 1078-1085
The acetylcholinesterase (AChE) inhibitor and anti-Alzheimer drug donepezil interacts with human erythrocytes
- 1 April 2019
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 665, 30-35
Antioxidant effect of resveratrol in single red blood cells measured by thermal fluctuation spectroscopy
- 1 April 2019
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 665, 30-35
Antioxidant effect of resveratrol in single red blood cells measured by thermal fluctuation spectroscopy
- 1 January 2018
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 178, 87-93
In vitro effects of benzimidazole/thioether-copper complexes with antitumor activity on human erythrocytes
- 1 January 2018
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 178, 87-93
In vitro effects of benzimidazole/thioether-copper complexes with antitumor activity on human erythrocytes
- 13 October 2016
- Published by Springer Nature in The Journal of Membrane Biology
- Vol. 249 (6) , 823-831
Effects of Thimerosal on Lipid Bilayers and Human Erythrocytes: An In Vitro Study
Thimerosal (THI, ethyl-mercury thiosalicylate) is added to vaccines as a preservative; as a consequence, infants may have been exposed to bolus doses of Hg that collectively added up to nominally 200 µg Hg during the first 6 months of life. While several studies report an association between THI-containing vaccines and neurological disorders, other studies do not support the causal relation between THI and autism. With the purpose to understand the molecular mechanisms of the toxic effect of THI it was assayed on human red cells and in bilayers built-up of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE), classes of phospholipids found in the outer and inner monolayers of the human erythrocyte membrane, respectively. The capacity of THI to interact with DMPC and DMPE was determined by X-ray diffraction and differential scanning calorimetry, whereas intact human erythrocytes were observed by optical, defocusing and scanning electron microscopy. The experimental findings of this study demonstrated that THI interacted in a concentration-dependent manner with DMPC and DMPE bilayers, and in vitro interacted with erythrocytes inducing morphological changes. However, concentrations were considerable higher than those present in vaccines.
- 13 October 2016
- Published by Springer Nature in The Journal of Membrane Biology
- Vol. 249 (6) , 823-831
Effects of Thimerosal on Lipid Bilayers and Human Erythrocytes: An In Vitro Study
Thimerosal (THI, ethyl-mercury thiosalicylate) is added to vaccines as a preservative; as a consequence, infants may have been exposed to bolus doses of Hg that collectively added up to nominally 200 µg Hg during the first 6 months of life. While several studies report an association between THI-containing vaccines and neurological disorders, other studies do not support the causal relation between THI and autism. With the purpose to understand the molecular mechanisms of the toxic effect of THI it was assayed on human red cells and in bilayers built-up of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE), classes of phospholipids found in the outer and inner monolayers of the human erythrocyte membrane, respectively. The capacity of THI to interact with DMPC and DMPE was determined by X-ray diffraction and differential scanning calorimetry, whereas intact human erythrocytes were observed by optical, defocusing and scanning electron microscopy. The experimental findings of this study demonstrated that THI interacted in a concentration-dependent manner with DMPC and DMPE bilayers, and in vitro interacted with erythrocytes inducing morphological changes. However, concentrations were considerable higher than those present in vaccines.